Group One Trading, L.P. United Therapeutics Corp Transaction History

Group One Trading, L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$228.26 - $319.04 $124,401 - $173,876	545 New	545 $173,000
Q3 2023 Nov 09, 2023	BUY	$211.82 - $248.24 $73,925 - $86,635	349 New	349 $78,000
Q1 2023 May 12, 2023	BUY	$212.99 - $276.17 $1.75 Million - $2.26 Million	8,196 New	8,196 $1.84 Million
Q2 2020 Aug 13, 2020	SELL	$92.74 - $125.82 $2,782 - $3,774	-30 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$79.39 - $115.35 $158,780 - $230,700	-2,000 Reduced 98.52%	30 $3,000
Q4 2019 Feb 10, 2020	BUY	$78.31 - $95.34 $158,969 - $193,540	2,030 New	2,030 $179,000
Q4 2017 Feb 09, 2018	SELL	$118.58 - $151.28 $11,858 - $15,128	-100 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$114.6 - $136.81 $11,460 - $13,681	100	100 $12,000

668

42.8M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.6B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.